Madri­gal rais­es $500M for NASH drug launch, dis­clos­es cy­ber­at­tack

Madri­gal Phar­ma­ceu­ti­cals ex­pects to raise $500 mil­lion from a stock and war­rants sale, which it plans to use to pre­pare for the launch of resme­tirom …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.